Education
About Us
Working with TipRanks
Follow Us
Senti Biosciences (SNTI)
NASDAQ:SNTI
Total Valuation
Senti Biosciences has a market cap or net worth of $54.16M. The enterprise value is $64.77M.
Market Cap$54.16M
Enterprise Value$64.77M
Share Statistics
Senti Biosciences has 26,290,838 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,290,838
Owned by Insiders65.85%
Owned by Institutions17.74%
Financial Efficiency
Senti Biosciences’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -68.24%.
Return on Equity (ROE)-2.06
Return on Assets (ROA)-0.54
Return on Invested Capital (ROIC)-68.24%
Return on Capital Employed (ROCE)-0.72
Revenue Per Employee0.00
Profits Per Employee-1.55M
Employee Count34
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Senti Biosciences is ―. Senti Biosciences’s PEG ratio is 0.00677.
PE Ratio―
PS Ratio0.00
PB Ratio0.63
Price to Fair Value0.63
Price to FCF-0.39
Price to Operating Cash Flow-1.09
PEG Ratio0.00677
Income Statement
In the last 12 months, Senti Biosciences had revenue of 0.00 and earned -52.79M in profits. Earnings per share was -11.49.
Revenue0.00
Gross Profit0.00
Operating Income-61.04M
Pretax Income-52.79M
Net Income-52.79M
EBITDA-54.88M
Earnings Per Share (EPS)-11.49
Cash Flow
In the last 12 months, operating cash flow was -50.07M and capital expenditures -207.00K, giving a free cash flow of -50.28M billion.
Operating Cash Flow-50.07M
Free Cash Flow-50.28M
Free Cash Flow per Share-1.91
Dividends & Yields
Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.93
52-Week Price Change-71.15%
50-Day Moving Average1.85
200-Day Moving Average2.48
Relative Strength Index (RSI)55.10
Average Volume (3m)260.00K
Important Dates
Senti Biosciences upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Senti Biosciences as a current ratio of 4.49, with Debt / Equity ratio of 370.90%
Current Ratio4.49
Quick Ratio4.49
Debt to Market Cap0.00
Net Debt to EBITDA0.27
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Senti Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Senti Biosciences EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.
EV to Sales0.00
EV to EBITDA-0.03
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Senti Biosciences has $12.24M in cash and marketable securities with $30.12M in debt, giving a net cash position of -$17.88M billion.
Cash & Marketable Securities$12.24M
Total Debt$30.12M
Net Cash-$17.88M
Net Cash Per Share-$0.68
Tangible Book Value Per Share$5.58
Margins
Gross margin is 24.80%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin24.80%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Senti Biosciences is $10.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.00
Price Target Upside385.44% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast78.60%